News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

TEAMM Pharmaceuticals, Inc., An Accentia BioPharmaceuticals Company, Announces The Signing Of A Marketing And Sales Agreement With Arius Pharmaceuticals


10/19/2005 5:08:46 PM

TEAMM Pharmaceuticals, the commercial arm of Accentia BioPharmaceuticals, announced today the signing of a marketing and sales agreement with Arius Pharmaceuticals, Inc. for the exclusive rights to market and sell Arius's product for treatment of nausea and vomiting. TEAMM Pharmaceuticals is focused on targeted therapies in the areas of respiratory, pain, oncology and critical care.

Read at BioSpace.com


comments powered by Disqus
   
Nausea

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES